Evaluation of the Pharmacokinetic Interaction between Venetoclax, a Selective BCL-2 Inhibitor, and Warfarin in Healthy Volunteers.
about
Effect of ketoconazole, a strong CYP3A inhibitor, on the pharmacokinetics of venetoclax, a BCL-2 inhibitor, in patients with non-Hodgkin lymphoma.Moving Beyond Maximum Tolerated Dose for Targeted Oncology Drugs: Use of Clinical Utility Index to Optimize Venetoclax Dosage in Multiple Myeloma Patients.Pharmacokinetics of the B-Cell Lymphoma 2 (Bcl-2) Inhibitor Venetoclax in Female Subjects with Systemic Lupus Erythematosus.Clinical evaluation of P-glycoprotein inhibition by venetoclax: a drug interaction study with digoxin.Pharmacokinetics of the BCL-2 Inhibitor Venetoclax in Healthy Chinese Subjects.Clinical pharmacokinetics of oral drugs in the treatment of multiple myeloma.Exposure-response evaluations of venetoclax efficacy and safety in patients with non-Hodgkin lymphoma.Impact of ritonavir dose and schedule on CYP3A inhibition and venetoclax clinical pharmacokinetics.Venetoclax: A novel B-cell lymphoma-2 inhibitor for chronic lymphocytic leukemia and other hematologic malignancies.
P2860
Q39177442-27D228CF-197D-497E-A044-AE88D1357C15Q45057327-4F7740EB-3BFF-4AE8-8ECE-A1EDE8DB82ABQ47553423-B4AE0CF5-F560-4A17-8E38-D713E70F3A71Q47610956-41C0F1CE-3CB6-4759-A976-54C84F20E8BCQ48146110-B2165674-631B-4636-B808-2A7B3D004C46Q48203285-D46D2841-17C6-413E-8C2C-C730D95B84A8Q48257454-BF696629-17D2-4454-8504-7F6FD40B0B92Q50119590-B215481D-C882-49FD-83DA-771B346BF5A9Q51842580-3E9EF5B3-9754-41EF-B9AA-6336F7365A12
P2860
Evaluation of the Pharmacokinetic Interaction between Venetoclax, a Selective BCL-2 Inhibitor, and Warfarin in Healthy Volunteers.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Evaluation of the Pharmacokine ...... arfarin in Healthy Volunteers.
@en
Evaluation of the Pharmacokine ...... arfarin in Healthy Volunteers.
@nl
type
label
Evaluation of the Pharmacokine ...... arfarin in Healthy Volunteers.
@en
Evaluation of the Pharmacokine ...... arfarin in Healthy Volunteers.
@nl
prefLabel
Evaluation of the Pharmacokine ...... arfarin in Healthy Volunteers.
@en
Evaluation of the Pharmacokine ...... arfarin in Healthy Volunteers.
@nl
P2093
P2860
P1476
Evaluation of the Pharmacokine ...... arfarin in Healthy Volunteers.
@en
P2093
Dilraj S Sidhu
Kevin J Freise
Shekman L Wong
P2860
P304
P356
10.1007/S40261-016-0485-9
P577
2016-12-02T00:00:00Z